Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.96 - $13.59 $13,723 - $23,429
-1,724 Reduced 8.55%
18,434 $155,000
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $273,342 - $418,883
20,158 New
20,158 $291,000
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $289,466 - $386,192
-2,095 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $239,018 - $304,843
2,095 New
2,095 $292,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $134M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.